文献速递前列腺癌

前列腺癌诊疗中的共享决策:鼓励每位患者积极参与还是确保患者偏好的参与程度?

Shared Decision Making in Prostate Cancer Care-Encouraging Every Patient to be Actively Involved in Decision Making or Ensuring the Patient Preferred Level of Involvement?
PubMed 文献 · J Urol · 2018-03-06

该前瞻性多中心观察研究纳入454例新诊断局限性前列腺癌患者,采用控制偏好量表评估治疗决策中的偏好与实际参与角色。87%患者报告实际积极参与决策,但17%患者的实际参与程度与偏好不匹配。积极参与决策与更多前列腺癌知识、更少决策冲突和更少决策后悔显著相关,角色一致性也与更少决策冲突相关但强度较弱。

要点

  • 87%局限性前列腺癌患者报告实际积极参与治疗决策,但17%的实际参与程度与偏好不匹配。
  • 积极参与决策与更多前列腺癌知识、更少决策冲突和更少决策后悔显著相关。
  • 角色一致性与更少决策冲突相关但强度弱于积极参与,支持鼓励所有患者积极参与决策。

核心结论

  • 研究结果支持鼓励所有局限性前列腺癌患者积极参与治疗决策,而不论其 stated 角色偏好如何。

研究设计与样本

  • 前瞻性、多中心、观察性研究,纳入454例新诊断局限性前列腺癌患者(cT1-cT2,或Gleason评分≤7且前列腺特异性抗原≤20 ng/ml)。
  • 在治疗前及治疗后3、6、12个月随访时收集系列问卷数据,临床数据来自患者医疗记录。
  • 使用控制偏好量表(CPS)操作化定义积极参与和角色一致性。

主要发现

  • 393例(87%)患者报告曾积极参与治疗决策。
  • 78例(17%)患者表示实际参与程度低于或高于其偏好。
  • 积极参与与更多前列腺癌知识显著相关(d=0.30)。
  • 积极参与与更少决策冲突显著相关(d=0.52)。
  • 积极参与与更少决策后悔显著相关(d=0.34)。

临床怎么用

  • 在前列腺癌治疗决策中,应鼓励所有患者积极参与,而不必仅局限于偏好积极参与者。
  • 促进患者积极参与可能改善知识、减少决策冲突和决策后悔。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aims of this study were to 1) describe preferred and experienced roles in treatment decision making among patients with localized prostate cancer, 2) identify how often the roles experienced by patients matched their preferred roles and 3) determine whether active involvement in decision making regardless of role preferences or concordance between preferred and experienced roles would be the strongest predictor of more favorable patient reported outcomes. MATERIALS AND METHODS: In this prospective, multicenter, observational study we obtained serial questionnaire data from 454 patients with newly diagnosed, localized prostate cancer (cT1-cT2, or Gleason 7 or less and prostate specific antigen 20 ng/ml or less). Questionnaires were completed prior to treatment and at the 3, 6 and 12-month posttreatment followups. Clinical data were obtained from the patient medical records. Active involvement and role concordance were operationalized using the CPS (Control Preferences Scale). ANOVA and effect sizes (small and medium Cohen d = 0.2 and 0.5, respectively) were used to compare patient knowledge of prostate cancer, decision conflict, decision regret and overall health related quality of life. RESULTS: Of the patients 393 (87%) reported having been actively involved in treatment decision making. However, 78 patients (17%) indicated having had less or more involvement than preferred. Active involvement was significantly associated with more prostate cancer knowledge (d = 0.30), less decision conflict (d = 0.52) and less decision regret (d = 0.34). Role concordance was also but less strongly associated with less decision conflict (d = 0.41). CONCLUSIONS: Our findings support a policy of encouraging all patients with localized prostate cancer regardless of their stated role preferences to be actively involved in the treatment decision.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. van Stam MA, Pieterse AH, van der Poel HG, et al. Shared Decision Making in Prostate Cancer Care-Encouraging Every Patient to be Actively Involved in Decision Making or Ensuring the Patient Preferred Level of Involvement? J Urol. 2018. PMID: 29501555. doi:10.1016/j.juro.2018.02.3091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。